Jefferies Financial Group Inc. Buys New Shares in Healthpeak Properties, Inc. $DOC

by · The Cerbat Gem

Jefferies Financial Group Inc. bought a new position in shares of Healthpeak Properties, Inc. (NYSE:DOCFree Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 38,775 shares of the real estate investment trust’s stock, valued at approximately $624,000.

A number of other large investors have also bought and sold shares of the stock. JPMorgan Chase & Co. raised its holdings in shares of Healthpeak Properties by 41.0% during the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after purchasing an additional 8,212,504 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Healthpeak Properties by 694.6% in the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after buying an additional 7,007,777 shares during the period. Equity Investment Corp grew its stake in shares of Healthpeak Properties by 209.6% in the 3rd quarter. Equity Investment Corp now owns 5,330,948 shares of the real estate investment trust’s stock valued at $102,088,000 after buying an additional 3,608,849 shares during the period. Bank of America Corp DE increased its position in Healthpeak Properties by 28.5% in the 3rd quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust’s stock valued at $190,292,000 after buying an additional 2,206,222 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its position in Healthpeak Properties by 176.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 3,063,569 shares of the real estate investment trust’s stock valued at $58,663,000 after buying an additional 1,955,273 shares in the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have commented on DOC. Wall Street Zen raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Argus cut Healthpeak Properties from a “buy” rating to a “hold” rating in a report on Thursday, February 5th. Evercore downgraded shares of Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price target for the company. in a research report on Monday, May 11th. Morgan Stanley boosted their price target on shares of Healthpeak Properties from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday, May 22nd. Finally, Citigroup upped their price objective on shares of Healthpeak Properties from $17.50 to $20.00 and gave the stock a “neutral” rating in a report on Tuesday, May 12th. Five investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $19.23.

Check Out Our Latest Stock Analysis on Healthpeak Properties

Healthpeak Properties Stock Performance

Shares of DOC opened at $19.17 on Friday. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The stock has a 50 day moving average price of $17.73 and a two-hundred day moving average price of $17.33. The firm has a market capitalization of $13.21 billion, a P/E ratio of 59.90, a P/E/G ratio of 2.48 and a beta of 1.00. Healthpeak Properties, Inc. has a 52 week low of $15.70 and a 52 week high of $20.27.

Healthpeak Properties (NYSE:DOCGet Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, topping the consensus estimate of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The firm had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. During the same period in the prior year, the business posted $0.46 earnings per share. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities analysts forecast that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 15th will be given a $0.1017 dividend. This represents a c) dividend on an annualized basis and a yield of 6.4%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties’s dividend payout ratio is presently 381.25%.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider directly owned 7,636 shares in the company, valued at approximately $148,520.20. This trade represents a 59.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.23% of the company’s stock.

About Healthpeak Properties

(Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

See Also